Amonafide

Drugbox
IUPAC_name = 5-amino-2- [2-(dimethylamino)ethyl] -1"H"-benzo ["de"] isoquinoline-1,3(2"H")-dione

---

CAS_number = 69408-81-7
ATC_prefix =
ATC_suffix =
PubChem = 50515
DrugBank =
C=16|H=17|N=3|O=3
molecular_weight = 283.325 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

Amonafide (INN, trade name Quinamed) is a drug that is being studied in the treatment of cancer. It belongs to the families of drugs called topoisomerase inhibitors and intercalating agents.

As of 2008, it is in Phase III clinical trials.

External links

* [http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=350223 Amonafide] entry in the public domain NCI Dictionary of Cancer Terms
* [http://www.clinicaltrials.gov/ct2/results?term=amonafide Clinical trials of amonafide] at ClinicalTrials.gov